Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
JNJ-87704916 by Johnson & Johnson for Solid Tumor: Likelihood of Approval
JNJ-87704916 is under clinical development by Johnson & Johnson and currently in Phase I for Solid Tumor. According to GlobalData,...
Data Insights
JNJ-87704916 by Johnson & Johnson for Non-Small Cell Lung Cancer: Likelihood of Approval
JNJ-87704916 is under clinical development by Johnson & Johnson and currently in Phase I for Non-Small Cell Lung Cancer. According...